Drug intelligence / Profile preview

mucuna pruriens

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

**Mucuna pruriens** is a tropical legume known for its high content of **L-DOPA (levodopa)**, a direct precursor to the neurotransmitter dopamine. It has a long history of use in **Ayurvedic medicine** for conditions such as **Parkinson's disease**, male infertility, nervous disorders, and as an aphrodisiac[1][4]. The primary mechanism of action is through its L-DOPA content, which increases dopamine concentrations in the brain and thereby mimics or supplements endogenous dopaminergic activity, especially relevant in Parkinson's disease. In addition to L-DOPA, Mucuna pruriens contains other bioactive compounds with reported antioxidant, anti-inflammatory, anti-neoplastic, anti-epileptic, and neuroprotective activities[1][5]. The seed and other plant extracts have also been noted for possible anti-diabetic, anti-microbial, anti-venom, analgesic, and anti-helminthic effects. In clinical studies, Mucuna pruriens seed extracts have shown comparable (and in some cases superior) efficacy to synthetic L-DOPA in reducing Parkinsonian motor symptoms, with potentially fewer side effects and greater neuroprotective activity[3][6]. Additionally, studies have indicated benefits for male infertility (improving sperm motility and quality), and ongoing research is investigating its effectiveness for mood disorders, cognitive enhancement, and metabolic regulation[2][4][8].

Other names
Mucuna pruriensvelvet beancowitchwerepekararaagbara
02

Targets

DRD2 (Dopamine D2 Receptor)DDC (Aromatic L-amino acid decarboxylase)DRD1 (Dopamine D1 Receptor)

Beyond the preview

Go deeper on mucuna pruriens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mucuna pruriens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call